Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC.

Choy H, Chakravarthy A, Devore RF, Jagasia M, Hande KR, Roberts JR, Johnson DH, Yunus F
Oncology (Williston Park). 2000 14 (7 Suppl 5): 43-6

PMID: 10981290

MeSH Terms (10)

Antineoplastic Agents, Phytogenic Camptothecin Carcinoma, Non-Small-Cell Lung Clinical Trials as Topic Combined Modality Therapy Drug Evaluation, Preclinical Humans Irinotecan Lung Neoplasms Radiation-Sensitizing Agents

Connections (3)

This publication is referenced by other Labnodes entities:

Links